Tiziana Life Sciences
TLSA
23 hedge funds and large institutions have $2.04M invested in Tiziana Life Sciences in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
0% more funds holding
Funds holding: 23 → 23 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
4.29% less ownership
Funds ownership: 5.73% → 1.44% (-4.3%)
84% less capital invested
Capital invested by funds: $13.1M → $2.04M (-$11M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$133K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$91K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$34.3K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$29.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$9.48M |
| 2 |
Morgan Stanley
New York
|
-$189K |
| 3 |
Renaissance Technologies
New York
|
-$153K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$135K |
| 5 |
OPS
Orion Portfolio Solutions
Omaha,
Nebraska
|
-$117K |
TLSA Hedge Fund Activity: Q3 2021 in Review
23 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q3 2021, worth a combined $2.04M — down 84% from $13.1M a quarter earlier.
Fund positioning in TLSA was balanced in Q3 2021: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 5 trimmed.
The largest buyer was State Street, adding an estimated $133K. The largest seller was HighTower Advisors, exiting entirely with an estimated $9.48M sold.
- 23 institutional investors held Tiziana Life Sciences (TLSA) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $2.04M of Tiziana Life Sciences stock for Q3 2021, down 84% quarter-over-quarter.
- 5 funds opened new Tiziana Life Sciences positions in Q3 2021 and 5 closed out, a net change of 0 holders.
- The largest Tiziana Life Sciences buyer in Q3 2021 was State Street, an estimated $133K added.
- The largest Tiziana Life Sciences seller in Q3 2021 was HighTower Advisors, an estimated $9.48M sold.
Based on aggregated 13F filings for Q3 2021.